Brief: Tango Therapeutics Q1 Basic EPS USD -0.36
12/05/2025 12:00
May 12 (Reuters) - Tango Therapeutics Q1 operating expenses USD 47.922 million. Q1 net income USD -39.876 million Q1 operating income USD -42.53 million
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,